scholarly article | Q13442814 |
P50 | author | Peter J. Hotez | Q7174738 |
Alex Loukas | Q30513842 | ||
John M. Hawdon | Q39063449 | ||
P2093 | author name string | Bin Zhan | |
Vehid Deumic | |||
Rachna Patel | |||
Sen Liu | |||
Susana Mendez | |||
Qun Jin | |||
Laura Hoffman | |||
Kashinath Ghosh | |||
Bernard C Zook | |||
Azra Dobardzic | |||
Reshad Dobardzic | |||
Yueyuan Liu | |||
Gaddam Narsa Goud | |||
Sophia Chung-Debose | |||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Ancylostoma ceylanicum | Q16974161 |
P304 | page(s) | 919-929 | |
P577 | publication date | 2004-02-06 | |
P1433 | published in | Journal of Infectious Diseases | Q4051141 |
P1476 | title | Cloning, yeast expression, isolation, and vaccine testing of recombinant Ancylostoma-secreted protein (ASP)-1 and ASP-2 from Ancylostoma ceylanicum | |
P478 | volume | 189 |
Q63984735 | A highly expressed intestinal cysteine protease of Ancylostoma ceylanicum protects vaccinated hamsters from hookworm infection |
Q27486084 | A novel, helminth-derived immunostimulant enhances human recall responses to hepatitis C virus and tetanus toxoid and is dependent on CD56+ cells for its action |
Q46875949 | A preliminary proteomic survey of the in vitro excretory/secretory products of fourth-stage larval and adult Teladorsagia circumcincta |
Q47245256 | Ancylostoma ceylanicum infective third-stage larvae are activated by co-culture with HT-29-MTX intestinal epithelial cells. |
Q24534649 | Biochemical characterization and vaccine potential of a heme-binding glutathione transferase from the adult hookworm Ancylostoma caninum |
Q64226736 | Comparative Extracellular Proteomics of Reveals Iron-Regulated Secreted Proteins as Potential Vaccine Candidates |
Q39013774 | Comparative immunology of human and animal models of hookworm infection |
Q38176075 | Controlling soil-transmitted helminths: time to think inside the box? |
Q33320897 | Developmentally regulated expression, alternative splicing and distinct sub-groupings in members of the Schistosoma mansoni venom allergen-like (SmVAL) gene family. |
Q39244367 | Effect of combining the larval antigens Ancylostoma secreted protein 2 (ASP-2) and metalloprotease 1 (MTP-1) in protecting hamsters against hookworm infection and disease caused by Ancylostoma ceylanicum |
Q37003207 | Evaluation of recombinant Onchocerca volvulus activation associated protein-1 (ASP-1) as a potent Th1-biased adjuvant with a panel of protein or peptide-based antigens and commercial inactivated vaccines |
Q34438394 | Expression of the Necator americanus hookworm larval antigen Na-ASP-2 in Pichia pastoris and purification of the recombinant protein for use in human clinical trials |
Q39624915 | Fusion of Na-ASP-2 with human immunoglobulin Fcγ abrogates histamine release from basophils sensitized with anti-Na-ASP-2 IgE. |
Q36635886 | Hookworm vaccines: past, present, and future |
Q21090197 | Hookworm: "the great infection of mankind". |
Q33788299 | Host cytokine production, lymphoproliferation, and antibody responses during the course of Ancylostoma ceylanicum infection in the Golden Syrian hamster |
Q24652391 | Human hookworm infection in the 21st century |
Q37390214 | Immune response studies with Wuchereria bancrofti vespid allergen homologue (WbVAH) in human lymphatic filariasis |
Q35317663 | Immunization with the recombinant antigen Ss-IR induces protective immunity to infection with Strongyloides stercoralis in mice |
Q57182005 | Ligand binding properties of two Brugia malayi fatty acid and retinol (FAR) binding proteins and their vaccine efficacies against challenge infection in gerbils |
Q28473882 | Massively parallel sequencing and analysis of the Necator americanus transcriptome |
Q34494931 | Molecular cloning, expression, and characterization of a putative activation-associated secreted protein from Angiostrongylus cantonensis. |
Q51790901 | Mucosal antibody responses in experimental hookworm infection. |
Q36608209 | Necator americanus: the Na-ASP-2 protein secreted by the infective larvae induces neutrophil recruitment in vivo and in vitro |
Q46299379 | Onchocerca volvulus: The Road from Basic Biology to a Vaccine |
Q30401512 | Optimization of the Production Process and Characterization of the Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1), a SARS Vaccine Candidate |
Q36215196 | Platyhelminth Venom Allergen-Like (VAL) proteins: revealing structural diversity, class-specific features and biological associations across the phylum. |
Q34768601 | Randomized, placebo-controlled, double-blind trial of the Na-ASP-2 hookworm vaccine in unexposed adults |
Q35690054 | Reduction of worm fecundity and canine host blood loss mediates protection against hookworm infection elicited by vaccination with recombinant Ac-16. |
Q28238731 | Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm |
Q43299440 | Standardization of an experimental model of human taeniosis for oral vaccination. |
Q27667719 | Structure of a two-CAP-domain protein from the human hookworm parasiteNecator americanus |
Q33550595 | Survey of transcripts expressed by the invasive juvenile stage of the liver fluke Fasciola hepatica |
Q37291569 | The hookworm Ancylostoma ceylanicum intestinal transcriptome provides a platform for selecting drug and vaccine candidates |
Q58697748 | Trichuris muris whey acidic protein induces type 2 protective immunity against whipworm |
Q90324839 | Twenty-five-year research progress in hookworm excretory/secretory products |
Q39244361 | Use of the air pouch model to investigate immune responses to a hookworm vaccine containing the Na-ASP-2 protein in rats |
Q49043311 | Vaccination against Ostertagia ostertagi with subfractions of the protective ES-thiol fraction |
Q27303702 | Vaccination of Gerbils with Bm-103 and Bm-RAL-2 Concurrently or as a Fusion Protein Confers Consistent and Improved Protection against Brugia malayi Infection |
Q21563438 | Vaccination with recombinant aspartic hemoglobinase reduces parasite load and blood loss after hookworm infection in dogs |
Q45014438 | Vaccine testing of a recombinant activation-associated secreted protein (ASP1) from Ostertagia ostertagi |
Q36726742 | Vaccines against blood-feeding nematodes of humans and livestock |
Q33987818 | Vaccines to combat river blindness: expression, selection and formulation of vaccines against infection with Onchocerca volvulus in a mouse model |
Q30425005 | Vaccines to combat the neglected tropical diseases |
Q27646442 | X-ray structures of Na-GST-1 and Na-GST-2 two glutathione s-transferase from the human hookworm Necator americanus |
Q39584080 | Yeast-expressed recombinant As16 protects mice against Ascaris suum infection through induction of a Th2-skewed immune response |
Q30218075 | Yeast-expressed recombinant protein of the receptor-binding domain in SARS-CoV spike protein with deglycosylated forms as a SARS vaccine candidate |
Q81661824 | rOv-ASP-1, a recombinant secreted protein of the helminth Onchocercavolvulus, is a potent adjuvant for inducing antibodies to ovalbumin, HIV-1 polypeptide and SARS-CoV peptide antigens |
Search more.